Am J Gastroenterol

1. ZHANG X, Daniel CR, Soltero V, Vargas X, et al
   A Study of Dietary Patterns Derived by Cluster Analysis and Their Association With Metabolic Dysfunction-Associated Steatotic Liver Disease Severity Among Hispanic Patients.
   Am J Gastroenterol. 2024;119:505-511.
   

   >> Share

   
   

   
   BMC Cancer

2. TANG Z, Bai T, Wei T, Wang X, et al
   TACE combined Lenvatinib plus Camrelizumab versus TACE alone in efficacy and safety for unresectable hepatocellular carcinoma: a propensity score-matching study.
   BMC Cancer. 2024;24:717.
   

   >> Share

   
   
3. LIU S, Zhang S, Dong H, Jin X, et al
   CD63 + tumor-associated macrophages drive the progression of hepatocellular carcinoma through the induction of epithelial-mesenchymal transition and lipid reprogramming.
   BMC Cancer. 2024;24:698.
   

   >> Share

   
   
4. YAN X, Li Y, Qin W, Liao J, et al
   Radiomics model based on contrast-enhanced computed tomography imaging for early recurrence monitoring after radical resection of AFP-negative hepatocellular carcinoma.
   BMC Cancer. 2024;24:700.
   

   >> Share

   
   

   
   BMC Gastroenterol

5. WANG G, Zhang J, Liu H, Zheng Q, et al
   Embolization alone is as effective as TACE for unresectable HCC: systematic review and meta-analysis of randomized controlled trails.
   BMC Gastroenterol. 2024;24:195.
   

   >> Share

   
   

   
   Dig Dis

6. NEYE RM, Kircheis G, Stratmann D, Hilger N, et al
   Assessment of Cirrhotic Patients by the EncephalApp Fails to Predict Low-Grade Hepatic Encephalopathy.
   Dig Dis. 2024 Jun 12. doi: 10.1159/000538924.
   

   >> Share

   
   

   
   Dig Dis Sci

7. JINDAL A, Singh H, Kumar G, Arora V, et al
   Early Versus Standard Initiation of Terlipressin for Acute Kidney Injury in ACLF: A Randomized Controlled Trial (eTerli Study).
   Dig Dis Sci. 2024;69:2204-2214.
   

   >> Share

   
   
8. HANSEN S, Gilroy R, Lindsay I, Doty JR, et al
   A Meta-Analysis of Cumulative Incidence of Hepatocellular Carcinoma After the Fontan Operation.
   Dig Dis Sci. 2024 Jun 13. doi: 10.1007/s10620-024-08470.
   

   >> Share

   
   

   
   Endoscopy

9. VARGAS-MADRIGAL J, Chan SM, Dhar J, Teoh AYB, et al
   FEASIBILITY AND SAFETY OF A DEDICATED CAUTERY-ENHANCED TUBULAR SELF-EXPANDABLE METAL STENT FOR ENDOSCOPIC ULTRASOUND-GUIDED HEPATICOGASTROSTOMY.
   Endoscopy. 2024 Jun 7. doi: 10.1055/a-2340-7432.
   

   >> Share

   
   
10. SU HJ, Lin TA, Chen SY, Tsai MC, et al
    Cystogastrostomy as an alternative treatment for recurrent huge infected hepatic cyst.
    Endoscopy. 2024;56.
    

    >> Share

    
    
11. ALTONBARY AY, Sabry F, Hakim H, Seif S, et al
    Endoscopic ultrasound-guided cyanoacrylate injection into the perforating vein for high-risk gastric varices.
    Endoscopy. 2024;56.
    

    >> Share

    
    

    
    Eur Radiol

12. VAN DER REIJD DJ, Guerendel C, Staal FCR, Busard MP, et al
    Independent validation of CT radiomics models in colorectal liver metastases: predicting local tumour progression after ablation.
    Eur Radiol. 2024;34:3635-3643.
    

    >> Share

    
    
13. DUMAN S, Kuru D, Gumussoy M, Kiremitci S, et al
    A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone.
    Eur Radiol. 2024;34:3882-3888.
    

    >> Share

    
    

    
    Gastroenterology

14. HSU BY, Driscoll J, Tateno C, Mattis AN, et al
    Human Hepatocytes Can Give Rise To Intrahepatic Cholangiocarcinomas.
    Gastroenterology. 2024 Jun 10:S0016-5085(24)05028.
    

    >> Share

    
    

    
    Gut

15. KEGGENHOFF FL, Castven D, Becker D, Stojkovic S, et al
    PARP-1 selectively impairs KRAS-driven phenotypic and molecular features in intrahepatic cholangiocarcinoma.
    Gut. 2024 Jun 10:gutjnl-2023-331237. doi: 10.1136/gutjnl-2023-331237.
    

    >> Share

    
    

    
    Indian J Gastroenterol

16. ROY A, Premkumar M, Tiwary I, Tiwari S, et al
    Point-of-care ultrasound permits early initiation of terlipressin in suspected hepatorenal syndrome-acute kidney injury: A single arm proof-of-concept report.
    Indian J Gastroenterol. 2024 Jun 12. doi: 10.1007/s12664-024-01608.
    

    >> Share

    
    
17. MAJEED T, Sharma B, Sharma R, Bodh V, et al
    Sarcopenia in cirrhosis: Unraveling the prevalence and relationships with liver disease severity and complications.
    Indian J Gastroenterol. 2024 Jun 7. doi: 10.1007/s12664-024-01550.
    

    >> Share

    
    

    
    Int J Cancer

18. ZHAO L, Zhang X, Birmann BM, Danford CJ, et al
    Pre-diagnostic plasma inflammatory proteins and risk of hepatocellular carcinoma in three population-based cohort studies from the United States and the United Kingdom.
    Int J Cancer. 2024 Jun 11. doi: 10.1002/ijc.35054.
    

    >> Share

    
    

    
    J Comput Assist Tomogr

19. NAGATA H, Iori H, Yoshida S, Kawashima H, et al
    Simultaneous Injection of Contrast and Saline Using Spiral Flow-Generating Tube for Hepatic Dynamic Computed Tomography: Effect on Enhancement of Liver Parenchyma and Metastases to the Liver.
    J Comput Assist Tomogr. 2024 May 28. doi: 10.1097/RCT.0000000000001620.
    

    >> Share

    
    

    
    J Gastroenterol

20. MIWA T, Utakata Y, Hanai T, Aiba M, et al
    Acute kidney injury development is associated with mortality in Japanese patients with cirrhosis: impact of amino acid imbalance.
    J Gastroenterol. 2024 Jun 11. doi: 10.1007/s00535-024-02126.
    

    >> Share

    
    

    
    J Gastroenterol Hepatol

21. HO CT, Fu CC, Tan EC, Kao WY, et al
    The association between proton-pump inhibitor use and recurrence of hepatocellular carcinoma after hepatectomy.
    J Gastroenterol Hepatol. 2024 Jun 12. doi: 10.1111/jgh.16640.
    

    >> Share

    
    

    
    J Hepatol

22. PATMORE LA, Sonneveld MJ
    Reply 'Exploring hepatocellular carcinoma risks in sub-Saharan African and Afro-Surinamese individuals with chronic hepatitis B living in Europe'.
    J Hepatol. 2024 Jun 11:S0168-8278(24)02311-0. doi: 10.1016/j.jhep.2024.
    

    >> Share

    
    
23. SHAN D, Zhang G, Du Z
    Reevaluating Myosteatosis Criteria in Cirrhosis: Fluid and Gender Considerations.
    J Hepatol. 2024 Jun 9:S0168-8278(24)02309-2. doi: 10.1016/j.jhep.2024.
    

    >> Share

    
    
24. LAWITZ EJ, Fraessdorf M, Neff GW, Schattenberg JM, et al
    Efficacy, tolerability and pharmacokinetics of survodutide, a glucagon/glucagon-like peptide-1 receptor dual agonist, in cirrhosis.
    J Hepatol. 2024 Jun 7:S0168-8278(24)02303-1. doi: 10.1016/j.jhep.2024.
    

    >> Share

    
    
25. LI M, Bhoori S, Mehta N, Mazzaferro V, et al
    Immunotherapy for hepatocellular carcinoma: the next evolution in expanding access to liver transplantation.
    J Hepatol. 2024 Jun 5:S0168-8278(24)00423-9. doi: 10.1016/j.jhep.2024.
    

    >> Share

    
    

    
    N Engl J Med

26. LOOMBA R, Hartman ML, Lawitz EJ, Vuppalanchi R, et al
    Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis.
    N Engl J Med. 2024 Jun 8. doi: 10.1056/NEJMoa2401943.
    

    >> Share

    
    

    
    Oncogene

27. KE R, Viswakarma N, Menhart M, Singh SK, et al
    MLK3 promotes prooncogenic signaling in hepatocellular carcinoma via TGFbeta pathway.
    Oncogene. 2024 Jun 10. doi: 10.1038/s41388-024-03055.
    

    >> Share

    
    

    
    PLoS One

28. PENG T, Duong KS, Lu JY, Chacko KR, et al
    Incidence, characteristics, and risk factors of new liver disorders 3.5 years post COVID-19 pandemic in the Montefiore Health System in Bronx.
    PLoS One. 2024;19:e0303151.
    

    >> Share

    
    
29. PFISTERER N, Schwarz M, Schwarz C, Putre F, et al
    Statins, metformin, and RAS inhibitors did not reduce variceal bleeding risk and mortality in a large, real-life cohort of patients with cirrhosis.
    PLoS One. 2024;19:e0302811.
    

    >> Share

    
    
30. WANG F, Gan J, Li R, Yang R, et al
    Naringin from Ganshuang granule inhibits inflammatory to relieve liver fibrosis through TGF-beta-Smad signaling pathway.
    PLoS One. 2024;19:e0304185.
    

    >> Share

    
    
31. ZHANG R, Li S, Schippers K, Eimers B, et al
    Unraveling the impact of AXIN1 mutations on HCC development: Insights from CRISPR/Cas9 repaired AXIN1-mutant liver cancer cell lines.
    PLoS One. 2024;19:e0304607.
    

    >> Share

    
    

    
    Radiology

32. KIM PH, Hwang JY, Choi YH, Yoon HM, et al
    Safety of Gadoxetate Disodium for Hepatobiliary MRI in Children and Adolescents.
    Radiology. 2024;311:e232462.
    

    >> Share

    
    
33. OTERO HJ
    Gadoxetate Disodium Hepatobiliary Contrast Material Is Safe in Children and Adolescents.
    Radiology. 2024;311:e241082.
    

    >> Share

    
    

    
    Transplant Proc

34. ALMEIDA JD, Waisberg DR, Martino RB, Rocha-Santos V, et al
    Retransplantation for Late Hepatic Artery Thrombosis: Results from a Single Center.
    Transplant Proc. 2024 Jun 10:S0041-1345(24)00262.
    

    >> Share

    
    
35. VIEIRA IF, Waisberg DR, Rocha-Santos V, Pinheiro RS, et al
    Liver Transplantation for Benign Massive Hepatomegaly: Results From a Single Center and Contribution of the Left-to-Right Piggyback Approach.
    Transplant Proc. 2024 Jun 10:S0041-1345(24)00267.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share